Company

SANGAMO THERAPEUTICS, INC (SGMO)

Standardized SEC financial data for SANGAMO THERAPEUTICS, INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001001233 · OTC · Biological Products, (No Diagnostic Substances).

Operating margin

-306.5%

Net margin

-310.8%

Revenue growth (YoY)

-31.6%

Return on equity

861.6%

Free cash flow

-$97.3M

Current ratio

0.84×

EPS (diluted)

$-0.44

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$118.2M	$110.7M	$111.3M	$176.2M	$57.8M	$39.6M
R&D expense	$180.6M	$230.8M	$249.9M	$234.1M	$111.5M	$112.7M
SG&A expense	$67.1M	$63.2M	$62.7M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$132.8M	$180.4M	$307.5M	$81.0M	$43.4M	$20.9M
Total current assets	$659.7M	$398.8M	$300.3M	$94.3M	$51.7M	$35.8M
Property, plant & equipment	$41.3M	$51.5M	$63.5M	$26.9M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$169.9M	-$233.3M	-$223.6M	-$224.8M	-$67.1M	-$97.2M
Capital expenditures	$14.7M	$23.3M	$20.2M	$21.2M	$267K	$102K
Free cash flow	$155.2M	-$256.5M	-$243.8M	-$246.0M

Get SGMO data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/SGMO/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/SGMO/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View SGMO filings on SEC EDGAR →